Status:
COMPLETED
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Oral Doses of GLPG0634 in Healthy Subjects
Lead Sponsor:
Galapagos NV
Conditions:
Healthy
Eligibility:
MALE
40-60 years
Phase:
PHASE1
Brief Summary
The purpose of the study is to evaluate the safety and tolerability of multiple ascending oral doses of GLPG0634 given to healthy subjects for 10 days compared to placebo. During the course of the st...
Eligibility Criteria
Inclusion
- Healthy male, age 40-60 years
- BMI between 18-30 kg/m2
Exclusion
- Any condition that might interfere with the procedures or tests in this study
- Drug or alcohol abuse
- Smoking
Key Trial Info
Start Date :
August 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2011
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT01419990
Start Date
August 1 2011
End Date
October 1 2011
Last Update
August 15 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
SGS Stuivenberg
Antwerp, Antwerp, Belgium, 2060